NPI: 1598026908 · HANFORD, CA 93230 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/01/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/01/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,970 | $214K |
| 2019 | 7,701 | $211K |
| 2020 | 2,121 | $174K |
| 2021 | 4,940 | $271K |
| 2022 | 10,992 | $345K |
| 2023 | 14,840 | $421K |
| 2024 | 11,854 | $414K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 37,361 | 3,299 | $1.76M |
| 90945 | 5,943 | 219 | $246K | |
| A4657 | Syringe, with or without needle, each | 5,642 | 1,380 | $32K |
| 0250 | 1,103 | 105 | $12K | |
| J1756 | Injection, iron sucrose, 1 mg | 3,662 | 993 | $386.75 |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,490 | 227 | $226.80 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,054 | 554 | $150.62 |
| 83970 | 340 | 332 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 728 | 482 | $0.00 |
| 85048 | 261 | 252 | $0.00 | |
| 85041 | 277 | 264 | $0.00 | |
| 83540 | 124 | 116 | $0.00 | |
| 90662 | 12 | 12 | $0.00 | |
| 90661 | 12 | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 79 | 78 | $0.00 |
| 82728 | 123 | 115 | $0.00 | |
| 90674 | 46 | 46 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 86 | 68 | $0.00 |
| 83550 | 46 | 45 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 14 | $0.00 |
| 82607 | 15 | 15 | $0.00 |